Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
09/2005
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005CA2332134C Metal ligand containing bleaching compositions
09/20/2005CA2137243C Process for the production of n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl -1,4,7,10-tetraazacyclododecane and n-.beta.-hydroxyalkyl-tri-n-carboxyalkyl-1,4,8,11- tetraazacyclotetradecane derivatives and their metal compllexes
09/20/2005CA2125978C Improvements in chemical compounds
09/20/2005CA2084582C Process for the production of mono-n-substituted tetraaza macrocycles
09/15/2005WO2005085215A1 Anticancer agent
09/15/2005WO2005084658A1 Derivatives of actarit and their therapeutic use
09/15/2005US20050203173 PI-3 kinase inhibitor prodrugs
09/15/2005US20050203147 Biaryl heterocyclic compounds and methods of making and using the same
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/14/2005EP1572629A1 COMPOUNDS WHICH MODULATE PPARϝ TYPE RECEPTORS, AND USE THEREOF IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP0981343B1 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005048810A3 Sigma-2 receptor radiotracers for imaging the proliferative status of solid tumors
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/06/2005US6939967 Non-proteinogenic L-amino acids
09/01/2005WO2005080367A1 Ep2 receptor agonists
09/01/2005WO2005080356A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonits
09/01/2005WO2005080340A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005WO2005080322A1 Fluorene derivative
09/01/2005US20050192347 Urea and thiourea compounds and compositions for cholesterol management and related uses
09/01/2005CA2556263A1 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
09/01/2005CA2555814A1 Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents
09/01/2005CA2537079A1 Fluorene derivative
08/2005
08/31/2005CN1662518A Processes for producing epoxytriazole derivative and intermediate therefor
08/31/2005CN1216873C Valsartan salts
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936626 Retinoic acid mimetic anilides
08/30/2005US6936570 herbicides
08/30/2005US6936189 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/24/2005EP1565429A2 Aryl ureido derivatives and their medical use
08/24/2005EP1565422A1 Vitamin d receptor modulators
08/24/2005EP1144394B1 1-heterocycle substituted diarylamines
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/23/2005CA2153235C Compounds having selectivity for retinoid x receptors
08/18/2005WO2005075706A1 Surface-treating agent for metal
08/18/2005WO2005075462A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
08/18/2005WO2005075455A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
08/18/2005US20050182253 N,N,N',N'-tetrakis(2-quinolylmethyl)ethylenediamine; reacting with Zinc ions; inhibition of photoinduced electron transfer (PET)
08/18/2005CA2720312A1 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
08/18/2005CA2553246A1 Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives
08/17/2005EP1564200A1 Ketone compounds and compositions for cholesterol management and related uses
08/17/2005EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/17/2005EP1087943B1 Therapeutic biaryl derivatives
08/17/2005CN1656092A Robertson Graeme Michael et al.
08/17/2005CN1215063C Process for preparing 1, 4, 7, 10-tetranitrogen heterocydic dodecane-1, 4, 7-triacetic acid-N-substituted derivatives
08/17/2005CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050175543 Agents for magnetic imaging method
08/11/2005DE102004003710A1 Verwendung von Übergangsmetallkomplexen als Bleichkatalysatoren in Wasch- und Reinigungsmitteln Use of transition metal complexes as bleaching catalysts in detergents and cleaners
08/10/2005CN1652843A Methods for the treatment of respiratory diseases and conditions using a selective iNOS inhibitor
08/10/2005CN1652777A Combination of organic compounds
08/10/2005CN1214017C 四唑衍生物 Tetrazole derivatives
08/10/2005CN1214008C Therapeutic biaryl derivatives
08/10/2005CN1213999C Aliphatic amino carboxylic and amino phosphonic acids, amino nitriles and amino tetrazoles as cellular rescue agents
08/10/2005CN1213746C Immunopotentiatory agents and physiologically acceptable salts thereof
08/09/2005US6927224 Anticancer agents; osteoporosis
08/03/2005EP1558590A1 Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof
08/03/2005EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
08/02/2005US6924314 Compounds for the treatment of metabolic disorders
07/2005
07/28/2005WO2005068420A1 Urea and thiourea compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068418A1 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068412A1 Ketone compounds and compositions for cholesterol management and related uses
07/28/2005WO2005068410A1 Ether compounds and compositions for cholesterol management and related uses
07/28/2005US20050165075 Novel amorphous form of valsartan
07/28/2005US20050165018 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
07/28/2005US20050164954 formula (I) has an inhibitory activity against cysteine protease and therefore it is useful as an agent for the prophylaxis and/or treatment of inflammatory diseases, diseases induced by apoptosis, diseases induced by disorders of immune responses, autoimmune diseases, diseases induced by decomposition
07/27/2005EP1557457A1 Use of transition metal complexes as bleach catalysts in washing and cleaning agents
07/27/2005EP1556363A2 Process for the preparation of valsartan and intermediates thereof
07/27/2005EP1556330A2 Phenyl compounds
07/27/2005EP1556038A2 Acetophenone potentiators of metabotropic glutamate receptors
07/27/2005EP1078033B1 Metal ligand containing bleaching compositions
07/27/2005EP1047418B1 Inhibition of raf kinase using substituted heterocyclic ureas
07/27/2005CN1646116A Macrocyclic module compositions
07/26/2005CA2193388C Aryl and heteroaryl alkoxynaphthalene derivatives
07/26/2005CA2133439C Compounds useful for treating allergic and inflammatory diseases
07/21/2005US20050159467 5-Aryltetrazole compounds and uses thereof
07/21/2005US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders
07/21/2005DE10359026A1 Verfahren zur Herstellung von Tetrahydrogeranylaceton A process for preparing tetrahydrogeranylacetone
07/20/2005EP1555260A1 Phenyltetrazole compounds
07/20/2005EP1047677B1 Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid
07/20/2005CN1642925A Novel tetrazole derivative useful as herbicides
07/19/2005US6919375 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
07/19/2005US6919343 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
07/14/2005WO2005063705A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions
07/14/2005WO2005063690A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
07/14/2005WO2005062828A2 New compounds useful as metal chelators
07/14/2005WO2005051893A3 Vitamin d receptor modulators
07/14/2005WO2004113277A8 Methods and compositions for treating amyloid-related diseases
07/14/2005US20050154202 Substituted aryl amides
07/14/2005US20050154005 Administering to a subject in need of such treatment an effective amount of 1,1'-[1,4-(phenylenebis(methylene))]bis-1,4,8,11-tetraazacyclotetradecane or a pharmaceutical composition thereof, wherein the inhibition of CXCR4 receptor binding effects treatment or amelioration of said condition
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 97